ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer and infectious disease. ADVENTRX seeks to improve the performance and commercial potential of existing treatments by addressing limitations associated with these treatment regimens.

Our goal is to be a leading biopharmaceutical company focused on in-licensing, developing and commercializing proprietary p... More >>

Recent News

More >>

Date Title   07/01/08 ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R) 06/30/08 ADVENTRX Settles Dispute With Former Licensee 06/16/08 ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 06/03/08 ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)

Upcoming Events

More >>

There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.